Opening book details…
About this book
Antisense oligonucleotide DGAT-2 inhibitor, ION224, for metabolic dysfunction-associated steatohepatitis (ION224-CS2): results of a 51-week, multicentre, randomised, double-blind, placebo-controlled, phase 2 trial by Prof Rohit Loomba MD & Erin Morgan BS & Keyvan Yousefi PhD & Dan Li PhD & Richard Geary PhD & Sanjay Bhanot MD & Naim Alkhouri MD & ION224-CS2 Investigators is a book available to read on EtoBox.
- Author
- Prof Rohit Loomba MD & Erin Morgan BS & Keyvan Yousefi PhD & Dan Li PhD & Richard Geary PhD & Sanjay Bhanot MD & Naim Alkhouri MD & ION224-CS2 Investigators
- Publisher
- x
- Published
- 2025
- Language
- EN
More by Prof Rohit Loomba MD & Erin Morgan BS & Keyvan Yousefi PhD & Dan Li PhD & Richard Geary PhD & Sanjay Bhanot MD & Naim Alkhouri MD & ION224-CS2 Investigators
Similar books
- Safety and Efficacy of Once-weekly Efruxifermin Versus Placebo in Metabolic Dysfunction-associated Steatohepatitis (HARMONY): 96-week Results from a Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 2b Trial — Prof Mazen Noureddin MD & Juan P Frias MD & Guy W Neff MD & K Jean Lucas MD & Cynthia Behling MD & Pierre Bedossa MD & Julie Dubourg MD & Doreen Chan PhD & Mark Burch PhD & Erica Fong BS & Brittany de Temple BS & Matt Minerva BS & Kim Barrett BS &... (2025)
- Antisense Oligonucleotide Jacifusen for FUS-ALS: an Investigator-initiated, Multicentre, Open-label Case Series — Prof Neil A Shneider MD & Matthew B Harms MD & Vlad A Korobeynikov MD & Olivia M Rifai PhD & Benjamin N Hoover BA & Elizabeth A Harrington MS & Sonya Aziz-Zaman MS & Jessica Singleton BA & Arish Jamil BA & Vikram R Madan MPH & Ikjae Lee MD & Jinsy A... (2025)
- Stopping of Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis (ADJUST): a Multicentre, Double-masked, Randomised Controlled Trial — Prof Nisha R Acharya MD & Prof Athimalaipet V Ramanan FMedSci & Alison B Coyne MPH & Kathryn L Dudum MPH & Elia M Rubio MAS & Sydney M Woods BS & Catherine M Guly MBChB & Elena Moraitis PhD & Harry J D Petrushkin FRCOphth & Kate Armon DM & Narman... (2025)
- Spironolactone in Patients on Chronic Haemodialysis at High Risk of Adverse Cardiovascular Outcomes (ALCHEMIST): a Multicentre, Double-blind, Randomised, Placebo-controlled Trial and Updated Meta-analysis — Prof Patrick Rossignol MD & Prof Faiez Zannad MD & Prof Ziad Massy MD & Prof Michel Azizi MD & Fatima Chorfa MSc & Julien Coadic BSc & João Pedro Ferreira MD & Francisca Saraiva PhD & Prof Dominique Mottier MD & Prof Francis Guillemin MD & Willy... (2025)
- Spironolactone Versus Placebo in Patients Undergoing Maintenance Dialysis (ACHIEVE): an International, Parallel-group, Randomised Controlled Trial — Michael Walsh MD PhD & David Collister MD PhD & Martin Gallagher MBChB PhD & Patrick B Mark MBChB PhD & Janak R de Zoysa MBChB MClinEd & Jessica Tyrwhitt BSc & Karthik Tennankore MD MSc & Gilmar Reis MD PhD & Denis Xavier MD PhD & Wen J Liu MBChB & Li... (2025)
- The Clinical Effectiveness of Clarithromycin Versus Endoscopic Sinus Surgery for Adults with Chronic Rhinosinusitis with and Without Nasal Polyps (MACRO): a Pragmatic, Multicentre, Three-arm, Randomised, Placebo-controlled Phase 4 Trial — Prof Carl Philpott MD & Prof David J Beard DPhil & Elnaz Saeedi MSc & Prof Jonathan A Cook PhD & Stephen Jones BA Hons & Caroline S Clarke PhD & Lucinda Teoh PhD & Prof Mike Thomas PhD & Prof Paul Little FRCGP & Jane Vennik PhD & Prof Valerie Lund MS &... (2025)